Decitabine in Treating Patients With Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of decitabine in treating patients with
myelodysplastic syndrome.